Neogenomics Inc (NASDAQ:NEO)

11.46
Delayed Data
As of May 22
 +0.12 / +1.06%
Today’s Change
7.08
Today|||52-Week Range
11.63
+29.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line1.1M-2.5M-5.7M-846.0K
 
 
 
 
 
Depreciation5.6M7.1M23.2M22.6M
 
 
 
 
 
Total Other Cash Flow3.2M3.7M25.4M26.8M
 
 
 
 
 
Funds From Operations10.0M8.3M42.8M48.6M
 
 
 
 
 
Funds From/For Other Operating Expenses517.0K1.9M21.4M30.5M
 
 
 
 
 
Net Cash Flow - Operating Activities9.5M6.4M21.5M18.0M
 
 
 
 
 
 
InvestingCapital Expenditures-3.8M-2.2M-7.5M-13.7M
 
 
 
 
 
Fixed Asset Disposal----1.0M0.00
 
 
Net Assets From Acquisitions -5.8M-72.9M0.000.00
 
 
 
Net Cash Flow Investing-9.6M-75.2M-6.5M-13.7M
 
 
 
 
 
 
FinancingShort Term Borrowings-4.3M10.0M12.9M--
 
 
 
 
Long Term Borrowings0.0051.7M72.8M2.5M
 
 
 
 
Long Term Debt Reduction-3.6M-4.1M-115.3M-9.2M
 
 
 
 
 
Net Proceeds Stock Sale36.9M935.0K3.8M2.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.00--0.00--
Cash Dividends Paid - Total0.000.00--0.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing29.0M58.5M-25.9M-4.1M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00----44.0K
 
 
 
Net Change In Cash28.9M-10.3M-10.9M252.0K